Renato Corporation Shares in Pic-See, Inc.'s Patented Technological Achievements MIAMI, FL--(MARKET WIRE)--Oct 27, 2008 -- Renato Corporation's (Frankfurt:4OZ.F - News) investment
in Pic-See, Inc.'s patented, real-time three-dimensional
digital imaging
system has proven to be a huge success. "Anytime a company can contribute financially or otherwise to bring to the forefront new technology that will assist in the well being of mankind is a major accomplishment. Regardless of how big or small a part you play in bringing such advancements to completion is certainly rewarding for a company," stated Arunas Morkunas of Renato Corporation. Renato provided a direct investment toward the development of Pic-See's ophthalmic image processing and shares in the exclusive patented technology. Lenticular Online Assembly, or LOLA(TM), allows medical images such as x-rays and ophthalmological images to be rendered in 3D. Currently, x-rays and Ophthalmology images can be processed almost instantaneously over the Internet by LOLA(TM). LOLA(TM) enables Pic-See to produce objects with depth, as well as width and length. LOLA(TM) also makes it possible to assemble an image sequence that, when output to a printer or to a flat panel monitor, will create the illusion of motion. True 3D is not computer animation, a holographic image, nor is it 3D modeling. Close to 90% of the products claiming to be 3D are not products that create true 3D as we do. LOLA(TM) enables the secure exchange of images among disparate healthcare information systems and supports a broad range of healthcare image capture technology. Various medical hardware manufacturers will provide the service to the medical community as part of a bundled solution. Digital images are delivered to Pic-See over the Internet. Images from digital cameras, DVD, scanned photos, artwork, x-rays, and magnetic resonance imaging (MRI), etc. can all be processed by LOLA(TM). Renato Corporation intends to continue investing in Pic-See and other early detection diagnostic technologies that are developing new non-invasive devices and processes. About Renato Corporation At Renato Corporation it is the company's objective to provide diverse early detection diagnostic technologies utilizing its current experience, reputation and expertise within the international health care industry. Introducing and making available these non-invasive technologies through private health care firms and health and wellness centres in an affordable manner is our immediate focus. The company's mission is to carefully select where these advanced diagnostic technologies will be placed to ensure unparalleled delivery of customer service and satisfaction in the field of non-invasive early detection disease diagnosis and management. Innovative information technology platforms are enabling new models for more efficient, effective and safer healthcare delivery. It is inevitable, that the economic strain on today's health care systems worldwide will realize the ever increasing need for early detection diagnostic devices and services. Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations. Contact: Contact:
Arunas Morkunas
Director
Renato Corporation
305-456-7649 head office
416-572-2229 Canadian offices
http://www.renatocorp.com
Source: Renato Corporation
|